Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Inv. presentation
|
|
ARS Pharmaceuticals, Inc. (SBTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Sold 26,107 shares
@ $7.0103, valued at
$183k
Sold 18,897 shares
@ $7.0631, valued at
$133.5k
Exercised 26,017 options to buy
@ $1.27, valued at
$33k
Exercised 18,897 options to buy
@ $1.27, valued at
$24k
|
|
| 08/03/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Sold 18,715 shares
@ $7.1908, valued at
$134.6k
Sold 36,281 shares
@ $7.0909, valued at
$257.3k
Exercised 18,715 options to buy
@ $1.27, valued at
$23.8k
Exercised 36,281 options to buy
@ $1.27, valued at
$46.1k
|
|
| 07/07/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Sold 8,858 shares
@ $6.364, valued at
$56.4k
Exercised 8,858 options to buy
@ $1.27, valued at
$11.2k
|
|
| 07/06/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Sold 26,520 shares
@ $6.725, valued at
$178.3k
Sold 31,112 shares
@ $6.414, valued at
$199.6k
Sold 33,510 shares
@ $6.343, valued at
$212.6k
Exercised 26,520 options to buy
@ $1.27, valued at
$33.7k
Exercised 31,112 options to buy
@ $1.27, valued at
$39.5k
Exercised 33,510 options to buy
@ $1.27, valued at
$42.6k
|
|
| 06/28/2023 |
4
| Dadoo Rajeev (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.5, valued at
$260k
|
|
| 06/28/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.5, valued at
$260k
|
|
| 06/28/2023 |
4
| Kelly Michael (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.5, valued at
$260k
|
|
| 06/28/2023 |
4
| Shah Pratik (10% Owner) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.5, valued at
$260k
|
|
| 06/28/2023 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.5, valued at
$260k
|
|
| 06/28/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.5, valued at
$260k
|
|
| 06/28/2023 |
4
| SAUNDERS BRENT L (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.5, valued at
$260k
|
|
| 06/28/2023 |
4
| SCHNEIDER PHILLIP M (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.5, valued at
$260k
|
|
| 06/28/2023 |
4
| Islam Saqib (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.5, valued at
$260k
|
|
| 06/02/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Sold 73,059 shares
@ $6.8, valued at
$496.8k
Sold 26,941 shares
@ $6.95, valued at
$187.2k
Exercised 73,059 options to buy
@ $1.27, valued at
$92.8k
Exercised 26,941 options to buy
@ $1.27, valued at
$34.2k
|
|
| 05/10/2023 |
4
| Shawver Laura (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Sold 43,896 shares
@ $4.58, valued at
$201k
Sold 57,100 shares
@ $6.16, valued at
$351.7k
Sold 42,900 shares
@ $5.31, valued at
$227.8k
Exercised 57,100 options to buy
@ $1.27, valued at
$72.5k
Exercised 42,900 options to buy
@ $1.27, valued at
$54.5k
|
|
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Chakma Justin (Chief Business Officer) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 165,000 options to buy
@ $8.42, valued at
$1.4M
|
|
| 01/05/2023 |
4
| Dorsey Brian (COO) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 145,000 options to buy
@ $8.42, valued at
$1.2M
|
|
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Lowenthal Richard E (President and CEO) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 1,100,000 options to buy
@ $8.42, valued at
$9.3M
Granted 350,000 options to buy
@ $8.42, valued at
$2.9M
|
|
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Chakma Justin (Chief Business Officer) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 236,380 shares
@ $0
Granted 236,380 options to buy
@ $0.84, valued at
$198.6k
Granted 48,260 options to buy
@ $0.84, valued at
$40.5k
Granted 82,733 options to buy
@ $1.44, valued at
$119.1k
|
|
| 11/10/2022 |
4
| Shah Pratik (10% Owner) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 10,156,204 shares
@ $0
Granted 354,570 options to buy
@ $1.44, valued at
$510.6k
|
|
| 11/10/2022 |
4
| Karas Eric (Chief Commercial Officer) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 614,588 options to buy
@ $1.5, valued at
$921.9k
|
|
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Tanimoto Sarina (Chief Medical Officer) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 4,326,854 shares
@ $0
Granted 1,772,850 shares
@ $0
Granted 1,772,850 shares
@ $0
Granted 4,326,854 shares
@ $0
Granted 82,733 options to buy
@ $0.84, valued at
$69.5k
Granted 82,733 options to buy
@ $1.44, valued at
$119.1k
Granted 236,380 options to buy
@ $0.84, valued at
$198.6k
Granted 236,380 options to buy
@ $1.44, valued at
$340.4k
|
|
| 11/10/2022 |
4
| Lowenthal Richard E (President and CEO) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 5,176,822 shares
@ $0
Granted 1,772,850 shares
@ $0
Granted 4,326,854 shares
@ $0
Granted 1,772,850 shares
@ $0
Granted 236,380 options to buy
@ $0.84, valued at
$198.6k
Granted 236,380 options to buy
@ $1.44, valued at
$340.4k
Granted 82,733 options to buy
@ $0.84, valued at
$69.5k
Granted 82,733 options to buy
@ $1.44, valued at
$119.1k
|
|
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Kelly Michael (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 83,225 shares
@ $0
Granted 70,422 options to buy
@ $0.84, valued at
$59.2k
Granted 118,190 options to buy
@ $1.44, valued at
$170.2k
|
|
| 11/10/2022 |
4
| Dadoo Rajeev (Director) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 3,009,677 shares
@ $0 |
|
|
|
|